1-1 of 1
Vian Amber
Close
Sort by
Journal Articles

A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome

Clinical Trials & Observations
Caron A. Jacobson, Allison C. Rosenthal, Jon Arnason, Shirali Agarwal, Peixin Zhang, Wendy Wu, Vian Amber, Jean A. Yared
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6790–6799.
https://doi.org/10.1182/bloodadvances.2023009961
Published: 2023
Includes: Supplemental data